Different COVID-19 treatments’ impact on hospital length of stay

IMPORTANCE: COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients. OBJECTIVES: Is the combination therapy of dexameth...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Satori, Muhar, Bahaar Kaur, Chen, Hao, Chu, Harrison, Johnstone, Mason, Sidhu, Ashwin, Chu, Hillary, Fischer, Joseph, Chu, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316632/
https://www.ncbi.nlm.nih.gov/pubmed/37400927
http://dx.doi.org/10.1186/s40001-023-01201-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316632/
https://www.ncbi.nlm.nih.gov/pubmed/37400927
http://dx.doi.org/10.1186/s40001-023-01201-8

Ejemplares similares